AIROLDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 21.118
EU - Europa 11.645
AS - Asia 10.592
SA - Sud America 1.431
Continente sconosciuto - Info sul continente non disponibili 1.128
AF - Africa 246
OC - Oceania 36
Totale 46.196
Nazione #
US - Stati Uniti d'America 20.104
IT - Italia 3.802
SG - Singapore 3.036
CN - Cina 2.314
VN - Vietnam 2.274
DE - Germania 1.974
BR - Brasile 1.083
RU - Federazione Russa 1.031
HK - Hong Kong 1.022
SE - Svezia 866
CA - Canada 796
IE - Irlanda 563
PL - Polonia 553
GB - Regno Unito 540
FR - Francia 528
UA - Ucraina 422
IN - India 404
DK - Danimarca 366
BD - Bangladesh 334
FI - Finlandia 236
AT - Austria 168
TR - Turchia 158
ID - Indonesia 153
KR - Corea 150
ES - Italia 135
NL - Olanda 128
AR - Argentina 124
IQ - Iraq 115
JP - Giappone 109
MX - Messico 100
PK - Pakistan 95
ZA - Sudafrica 84
CH - Svizzera 75
PH - Filippine 58
SA - Arabia Saudita 56
UZ - Uzbekistan 52
EC - Ecuador 51
BE - Belgio 46
CL - Cile 42
RO - Romania 40
CO - Colombia 38
VE - Venezuela 33
EG - Egitto 29
LT - Lituania 29
PT - Portogallo 29
MY - Malesia 28
TW - Taiwan 27
AU - Australia 26
CZ - Repubblica Ceca 26
JO - Giordania 26
MA - Marocco 26
IR - Iran 25
JM - Giamaica 25
PE - Perù 24
DZ - Algeria 23
ET - Etiopia 22
CR - Costa Rica 19
NP - Nepal 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
GR - Grecia 16
HN - Honduras 16
KE - Kenya 16
LB - Libano 15
TH - Thailandia 14
AZ - Azerbaigian 11
BO - Bolivia 11
DO - Repubblica Dominicana 11
IL - Israele 11
OM - Oman 11
PY - Paraguay 11
UY - Uruguay 11
HU - Ungheria 9
PS - Palestinian Territory 9
SV - El Salvador 9
AL - Albania 8
BY - Bielorussia 8
EU - Europa 8
GE - Georgia 8
NI - Nicaragua 8
NZ - Nuova Zelanda 8
KZ - Kazakistan 7
RS - Serbia 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
GT - Guatemala 6
LV - Lettonia 6
PA - Panama 6
SN - Senegal 6
SY - Repubblica araba siriana 6
CY - Cipro 5
KG - Kirghizistan 5
AM - Armenia 4
BH - Bahrain 4
EE - Estonia 4
HR - Croazia 4
BB - Barbados 3
BS - Bahamas 3
KH - Cambogia 3
KW - Kuwait 3
Totale 45.015
Città #
Ann Arbor 4.738
Singapore 1.821
Ashburn 1.712
Milan 1.467
San Jose 1.247
Frankfurt am Main 1.233
Woodbridge 1.001
Hong Kong 980
Wilmington 924
Fairfield 846
Chandler 751
Ho Chi Minh City 626
Houston 597
Dublin 541
Hanoi 533
Toronto 480
Kraków 476
Dallas 471
New York 418
Jacksonville 403
Beijing 391
Seattle 383
Santa Clara 377
Council Bluffs 354
Los Angeles 352
Dearborn 290
Cambridge 281
Chicago 233
Columbus 219
Hefei 208
Rome 199
Princeton 198
The Dalles 198
Dong Ket 170
Vienna 135
Guangzhou 134
Nanjing 130
Seoul 128
Shanghai 126
Boardman 125
Buffalo 125
Lauterbourg 118
São Paulo 115
Helsinki 111
Jakarta 93
Lawrence 87
Orem 86
Moscow 83
Da Nang 79
Altamura 78
Phoenix 75
Munich 71
Brooklyn 67
Hangzhou 66
Montréal 64
Lachine 63
London 61
Haiphong 60
San Diego 60
Chennai 58
Tokyo 57
Kent 56
Montreal 55
Nuremberg 53
Baghdad 52
Denver 52
Warsaw 52
Zurich 52
Tashkent 48
Ottawa 45
Tianjin 45
Biên Hòa 43
Nanchang 43
Brussels 41
Desio 40
Manchester 40
Stockholm 40
Washington 40
Atlanta 39
Dhaka 39
Florence 39
Boston 38
Changsha 38
Fremont 38
Ha Long 38
Johannesburg 38
Poplar 37
Andover 36
Grafing 36
Turin 36
Brescia 35
Figino 35
Paris 35
Shenyang 35
Amsterdam 33
Hải Dương 33
Turku 33
Mexico City 32
Naples 32
Parma 31
Totale 29.156
Nome #
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 814
Coffee variety, origin and extraction procedure: Implications for coffee beneficial effects on human health 770
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 760
Green coffee extract enhances oxidative stress resistance and delays aging in Caenorhabditis elegans 740
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 693
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 667
Xanthohumol destabilizes the structure of amyloid-β (Aβ) oligomers and promotes the formation of high-molecular-weight amorphous aggregates 652
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 648
Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component 5-CQA on oncogenic Ras proteins 641
Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model 630
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 603
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 549
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 538
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model 529
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 522
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 515
Glycan carriers as glycotools for medicinal chemistry applications 513
Re LPS biogenetic pathway: Enzyme characterisation and synthetic efforts towards inhibitors 507
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 507
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide 498
Glycoconjugates in cancer therapy 494
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 484
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 478
Studies on the mechanism of action of a new class of inhibitors of Ras activation 471
Nuclear Magnetic Resonance as an Attractive Resource for Monitoring Surveillance Candidates of Acute and Chronic Lung Disorders 460
Flavonoids in the treatment of alzheimer’s and other neurodegenerative diseases 451
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 444
bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium 421
Effectiveness of Vigna unguiculata seed extracts in preventing colorectal cancer 412
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 410
From cancer metabolism to new biomarkers and drug targets 404
How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode 401
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 399
Phosphonate Analogues of Arabinose 5-Phosphate: Putative Ligands for Arabinose 5-Phosphate Isomerases 395
New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface 391
Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors 390
Natural glycoconjugates with antitumor activity 388
Methionine supplementation stimulates mitochondrial respiration 384
Targeting bacterial biofilm: a new LecA multivalent ligand with inhibitory activity 379
Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid b1-42 peptide 379
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 378
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 377
Flavonoids and their glycosides as anti-amyloidogenic compounds: Aβ1-42 interaction studies to gain new insights on their potential for Alzheimer's disease prevention and therapy 371
Metabolomic profiling of beers: Combining 1H NMR spectroscopy and chemometric approaches to discriminate craft and industrial products 371
Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3 368
1H NMR to Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification 368
Versatile and efficient targeting using a single nanoparticulate platform: Application to cancer and alzheimer's disease 365
Towards a universal approach based on omics technologies for the quality control of food 362
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 362
Structural modifications of cis-glycofused benzopyran compounds and their influence on the binding to amyloid-β peptide 358
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 357
The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen 355
Synthesis and biological evaluation of arabinose 5-phosphate mimics modified at position five 355
Curcumin derivatives as new ligands of Aβ peptides 353
Carbohydrate Mimetics and Scaffolds: Sweet Spots in Medicinal Chemistry 347
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors 346
Targeting bacterial membranes: NMR spectroscopy characterization of substrate recognition and binding requirements of D-arabinose-5-phosphate isomerase 346
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 344
Carbohyrate scaffolds in chemical genetic studies 343
Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases 341
Cheese-whey permeate improves the fitness of Escherichia coli cells during recombinant protein production 339
Curcumin derivatives: Aβ-ligands as potential diagnostic and therapeutic tools for alzheimer's disease 335
NMR Molecular Recognition Studies for the Elucidation of Protein and Nucleic Acid Structure and Function 334
Antimicrobial peptides: Insights into membrane permeabilization, lipopolysaccharide fragmentation and application in plant disease control 323
On-cell NMR screening of multivalent ligands for bacterial targeting 316
Targeting Bacterial Membranes: Identification of Pseudomonas aeruginosaD-Arabinose-5P Isomerase and NMR Characterisation of its Substrate Recognition and Binding Properties 314
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 312
Fluorinated Arabinose-5-Phosphate Analogues as Potential Antibactericals 312
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 311
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 311
The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins 310
1H NMR to Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study 301
Fructose-based proline analogues: Exploring the prolyl trans/cis-amide rotamer population in model peptides 298
On-cell Saturation Transfer Difference NMR for the identification of FimH ligands and inhibitors 298
Nutraceutical approach to increase healthy aging using Caenorhabditis elegans as a model organism 297
Clustering Zwitterionic Amino Acids at the Upper Rim of Cone Calix[4]arene Triggers the Selective Recognition of Gram-Negative Bacterial Envelope 293
Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs 293
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6 292
Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer's disease 287
NMR Protein-Ligand Interaction Studies under Non-Homogeneous Conditions for Biomaterial Generation: A Model For Artificial Lectin-Carbohydrate Recognition 286
Cis-glyco-fused benzopyran compounds as new amyloid β peptide ligands 285
Tetracycline prevents Aβ oligomer toxicity through an atipical supramolecular interaction 285
Solid-phase supported mimic of GDP-l-galactose 281
Development of new potential antitumor drugs based on Ras protein inhibition 280
Antarctic Soil Metabolomics: A Pilot Study 278
Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1-42) 268
Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers 266
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 261
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment 258
Synthesis of C- and S-Glycosides 258
A Contribution to the Harmonization of Non-targeted NMR Methods for Data-Driven Food Authenticity Assessment 257
Synthesis of 3-Deoxy-D-threopentofuranose 5-Phosphate, a Substrate of Arabinose 5-Phosphate Isomerase 256
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors 251
Sugar-Based Enantiomeric and Conformationally Constrained Pyrrolo[2,1-c][1,4]-Benzodiazepines as Potential GABAALigands 251
Adjuvant Effect of Cinnamon Polyphenolic Components in Colorectal Cancer Cell Lines 249
Aβ Monomers, Oligomers and Fibrils: Structural Features 248
New C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. Therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents 244
Phytotoxicity, nematicidal activity and chemical constituents of Peucedanum ostruthium (L.) W.D.J.Koch (Apiaceae) 239
Saturation Transfer Difference NMR Experiments of Membrane Proteins in Living Cells under HR-MAS Conditions: the Interaction of the SGLT1 Co-transporter with Its Ligands 238
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 238
Totale 39.251
Categoria #
all - tutte 129.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.975 0 342 310 309 161 271 222 154 283 246 273 404
2022/20233.845 497 937 478 362 324 509 126 195 194 57 98 68
2023/20242.402 102 118 156 187 266 476 373 131 181 68 99 245
2024/20255.929 277 575 515 307 422 272 279 228 590 874 539 1.051
2025/202615.972 2.057 1.111 1.263 1.700 1.696 716 2.334 622 1.107 1.332 837 1.197
2026/20271.321 533 788 0 0 0 0 0 0 0 0 0 0
Totale 46.196